1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Gene Therapy
  6.  » Formulation Strategies for AAV-Based Gene Therapies

Formulation Strategies for AAV-Based Gene Therapies

Summary: Formulation studies for gene therapy products are currently limited in scope and revolve around gathering stability data at frozen storage conditions. A systematic approach towards understanding degradation mechanisms followed by buffer and excipient selection is required. In this executive summary, our expert discusses how Catalent Cell & Gene Therapy continues to learn about formulating gene therapies by adapting methods used for other biologics.


Click here to download the Executive Summary